Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Yu Chu

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
JAAD International|August 19, 2021
Prevalence of baseline comorbidities in patients with atopic dermatitis: A population-based cohort study in TaiwanYung-Tsu Cho, Wen-Ting Hsieh, Tom C Chan, et al.
Biomedicines|May 28, 2022
Clinical, Histopathologic, and Immunohistochemical Features of Patients with IgG/IgA PemphigusYung-Tsu Cho, Ko-Ting Fu, Kai-Lung Chen, et al.
Journal of the American Academy of Dermatology|November 19, 2013
Reply to: "Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms"Yi-Chun Chen, Chia-Ying Chang, Yung-Tsu Cho, et al.
Journal of the American Academy of Dermatology|September 11, 2012
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from TaiwanYi-Chun Chen, Chia-Ying Chang, Yung-Tsu Cho, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2022
Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitorsHui-Te Hsu, Chu-Chun Yu, Yun-Hsiang Lee, et al.
The World Allergy Organization Journal|September 28, 2020
Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year resultsMarcus Maurer, Ana Giménez-Arnau, Luis Felipe Ensina, et al.
Acta Dermato-Venereologica|September 25, 2025
Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte ratio, and Lymphocyte- to-Monocyte Ratio in Extramammary Paget's Disease: A Retrospective StudyWen-Hsin Yu, Che-Chia Hsu, Yi-Hua Liao, et al.
Journal of the American Academy of Dermatology|July 5, 2025
Response to Solak et al., "Reply to "Pretreatment neutrophil-to-lymphocyte ratio predicts survival in primary mucosal melanoma""Chian-Tzu Huang, Yi-Hua Liao, Jau-Yu Liau, et al.
Acta Dermato-Venereologica|June 15, 2026
Clinical and Pathological Predictors of Unfavourable Outcomes in Thin and In Situ Melanomas: A Retrospective Cohort Study from TaiwanGuan-Kai Lai, Yi-Hua Liao, Ming-Hsien Lin, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Pretreatment neutrophil-to-lymphocyte ratio predicts survival in primary mucosal melanomaChian-Tzu Huang, Yi-Hua Liao, Jau-Yu Liau, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
JAAD International|August 19, 2021
Prevalence of baseline comorbidities in patients with atopic dermatitis: A population-based cohort study in TaiwanYung-Tsu Cho, Wen-Ting Hsieh, Tom C Chan, et al.
Biomedicines|May 28, 2022
Clinical, Histopathologic, and Immunohistochemical Features of Patients with IgG/IgA PemphigusYung-Tsu Cho, Ko-Ting Fu, Kai-Lung Chen, et al.
Journal of the American Academy of Dermatology|November 19, 2013
Reply to: "Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms"Yi-Chun Chen, Chia-Ying Chang, Yung-Tsu Cho, et al.
Journal of the American Academy of Dermatology|September 11, 2012
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from TaiwanYi-Chun Chen, Chia-Ying Chang, Yung-Tsu Cho, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2022
Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitorsHui-Te Hsu, Chu-Chun Yu, Yun-Hsiang Lee, et al.
The World Allergy Organization Journal|September 28, 2020
Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year resultsMarcus Maurer, Ana Giménez-Arnau, Luis Felipe Ensina, et al.
Acta Dermato-Venereologica|September 25, 2025
Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte ratio, and Lymphocyte- to-Monocyte Ratio in Extramammary Paget's Disease: A Retrospective StudyWen-Hsin Yu, Che-Chia Hsu, Yi-Hua Liao, et al.
Journal of the American Academy of Dermatology|July 5, 2025
Response to Solak et al., "Reply to "Pretreatment neutrophil-to-lymphocyte ratio predicts survival in primary mucosal melanoma""Chian-Tzu Huang, Yi-Hua Liao, Jau-Yu Liau, et al.
Acta Dermato-Venereologica|June 15, 2026
Clinical and Pathological Predictors of Unfavourable Outcomes in Thin and In Situ Melanomas: A Retrospective Cohort Study from TaiwanGuan-Kai Lai, Yi-Hua Liao, Ming-Hsien Lin, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Pretreatment neutrophil-to-lymphocyte ratio predicts survival in primary mucosal melanomaChian-Tzu Huang, Yi-Hua Liao, Jau-Yu Liau, et al.
Pageof 22